Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
17 09 2019
Historique:
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 20 5 2020
Statut: epublish

Résumé

Strains of

Identifiants

pubmed: 31530672
pii: mBio.01822-19
doi: 10.1128/mBio.01822-19
pmc: PMC6751058
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azabicyclo Compounds 0
Drug Combinations 0
avibactam, ceftazidime drug combination 0
Ceftazidime 9M416Z9QNR

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BLRD VA
ID : I01 BX001974
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI063517
Pays : United States

Références

Trends Microbiol. 1999 Jan;7(1):29-36
pubmed: 10068995
Microbiology. 2002 May;148(Pt 5):1247-1252
pubmed: 11988499
PLoS Genet. 2018 Apr 27;14(4):e1007324
pubmed: 29702649
Virus Res. 2005 Feb;107(2):117-27
pubmed: 15649558
DNA Repair (Amst). 2003 May 13;2(5):593-608
pubmed: 12713816
Antimicrob Agents Chemother. 2014 Jun;58(6):3091-9
pubmed: 24637685
PLoS One. 2012;7(9):e44199
pubmed: 22970178
Res Microbiol. 2000 Mar;151(2):91-5
pubmed: 10865953
Antimicrob Agents Chemother. 2015 Sep;59(9):5324-30
pubmed: 26100712
Clin Microbiol Infect. 2014 Oct;20(10):O609-18
pubmed: 24422878
Science. 2000 Feb 25;287(5457):1479-82
pubmed: 10688795
Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):29-39
pubmed: 11205327
Cell. 2003 Apr 18;113(2):183-93
pubmed: 12705867
J Cyst Fibros. 2015 May;14(3):361-9
pubmed: 25563522
J Antimicrob Chemother. 2015;70(6):1650-8
pubmed: 25645206
mSphere. 2016 Sep 07;1(5):
pubmed: 27631025
Clin Infect Dis. 2003 Nov 1;37(9):1201-9
pubmed: 14557965
Cold Spring Harb Symp Quant Biol. 2000;65:11-9
pubmed: 12760016
Nat Commun. 2013;4:1610
pubmed: 23511474
Biol Lett. 2011 Jun 23;7(3):422-4
pubmed: 21227974
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2774-83
pubmed: 22991466
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13680-5
pubmed: 22869726
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082283
Antimicrob Agents Chemother. 2002 Mar;46(3):863-5
pubmed: 11850274
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242667
J Bacteriol. 1999 Mar;181(5):1576-84
pubmed: 10049391
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13374-6
pubmed: 12370416
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29263067
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14339-44
pubmed: 14617778
Annu Rev Microbiol. 2017 Sep 8;71:579-596
pubmed: 28697667
Curr Opin Microbiol. 2001 Oct;4(5):582-5
pubmed: 11587936
Genetics. 2000 Mar;154(3):959-70
pubmed: 10757746
Science. 2002 May 31;296(5573):1627-30
pubmed: 12040171
Sci Rep. 2019 Mar 18;9(1):4720
pubmed: 30886315
Clin Microbiol Infect. 2010 Jul;16(7):798-808
pubmed: 20880409
Nature. 1997 Jun 12;387(6634):700-2
pubmed: 9192893
Microbiology. 1999 Oct;145 ( Pt 10):2857-62
pubmed: 10537207
Science. 2001 Mar 30;291(5513):2606-8
pubmed: 11283373
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28947473
Antimicrob Agents Chemother. 2009 May;53(5):1766-71
pubmed: 19258272
Antimicrob Agents Chemother. 2016 Jan 04;60(3):1767-78
pubmed: 26729493
Science. 1996 Nov 15;274(5290):1208-11
pubmed: 8895473
J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529
pubmed: 29566151
J Antibiot (Tokyo). 2017 Apr;70(4):366-377
pubmed: 27899793
Trends Genet. 2010 Aug;26(8):345-52
pubmed: 20594608
Antimicrob Agents Chemother. 2012 Feb;56(2):1128-32
pubmed: 22123702
Evolution. 1983 Jan;37(1):125-134
pubmed: 28568016
J Bacteriol. 2002 Jan;184(2):605-9
pubmed: 11751844
Nat Rev Microbiol. 2018 Sep;16(9):523-539
pubmed: 30002505
Annu Rev Microbiol. 2018 Sep 08;72:209-230
pubmed: 30200850
Science. 2000 May 19;288(5469):1251-4
pubmed: 10818002
Open Biol. 2017 Sep;7(9):
pubmed: 28878043
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7160-4
pubmed: 1831267
Res Microbiol. 2004 Jun;155(5):337-41
pubmed: 15207865
Nat Ecol Evol. 2018 Jun;2(6):1033-1039
pubmed: 29686236
Nat Rev Microbiol. 2014 Jul;12(7):465-78
pubmed: 24861036
BMC Genomics. 2016 Jan 05;17:27
pubmed: 26732503
Fam Cancer. 2013 Jun;12(2):159-68
pubmed: 23572416
Genetics. 1998 Apr;148(4):1667-86
pubmed: 9560386
J Antimicrob Chemother. 2002 Jun;49(6):925-34
pubmed: 12039884
Mutat Res. 2010 Feb 3;684(1-2):56-65
pubmed: 19954745
Int J Antimicrob Agents. 2018 Nov;52(5):697-701
pubmed: 30081137
J Bacteriol. 1997 Jan;179(2):417-22
pubmed: 8990293
J Bacteriol. 2012 Dec;194(23):6387-9
pubmed: 22984262
PLoS Genet. 2017 Apr 19;13(4):e1006739
pubmed: 28422960
Antimicrob Agents Chemother. 2015 Oct;59(10):6605-7
pubmed: 26195508
J Mol Biol. 2009 May 29;389(1):134-45
pubmed: 19361527
Cell Res. 2008 Jan;18(1):184-97
pubmed: 18157156
Science. 2003 May 30;300(5624):1404-9
pubmed: 12775833
Biochem Biophys Res Commun. 2014 Oct 17;453(2):254-67
pubmed: 24878531
Q Rev Biophys. 1971 Aug;4(2):149-212
pubmed: 5134461
Mutat Res. 2000 Mar 14;448(1):47-55
pubmed: 10751622
Antimicrob Agents Chemother. 2005 May;49(5):1782-6
pubmed: 15855496
Nat Rev Genet. 2016 Oct 14;17(11):704-714
pubmed: 27739533
Drug Resist Updat. 2003 Jun;6(3):137-45
pubmed: 12860461
Science. 1997 Sep 19;277(5333):1833-4
pubmed: 9324769
mBio. 2017 Oct 31;8(5):
pubmed: 29089424

Auteurs

Pavel P Khil (PP)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Fredrick, Maryland, USA.

Augusto Dulanto Chiang (A)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Fredrick, Maryland, USA.

Jonathan Ho (J)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Jung-Ho Youn (JH)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Jamie K Lemon (JK)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Juan Gea-Banacloche (J)

Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, Maryland, USA.

Karen M Frank (KM)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Mark Parta (M)

Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Fredrick, Maryland, USA.

Robert A Bonomo (RA)

CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA.
Medical Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Case Center for Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

John P Dekker (JP)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA john.dekker@nih.gov.
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Fredrick, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH